In 2006, Berlex’s German affiliate was acquired by Bayer to form Bayer HealthCare Pharmaceuticals, creating the seventh largest specialty pharmaceutical company worldwide with more than $11.7 billion in annual revenues. The combined company’s core strengths in specialty pharmaceuticals include Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology, Primary Care, and Oncology.